MX9301343A - Derivados peptidicos antiherpes, isostericos y procedimiento para su preparacion. - Google Patents

Derivados peptidicos antiherpes, isostericos y procedimiento para su preparacion.

Info

Publication number
MX9301343A
MX9301343A MX9301343A MX9301343A MX9301343A MX 9301343 A MX9301343 A MX 9301343A MX 9301343 A MX9301343 A MX 9301343A MX 9301343 A MX9301343 A MX 9301343A MX 9301343 A MX9301343 A MX 9301343A
Authority
MX
Mexico
Prior art keywords
alkyl
amino acid
isosterics
antiherpes
procedure
Prior art date
Application number
MX9301343A
Other languages
English (en)
Spanish (es)
Inventor
Pierre-Louis Beaulieu
Robert Deziel
Neil Moss
Raymond Plante
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Publication of MX9301343A publication Critical patent/MX9301343A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9301343A 1992-03-12 1993-03-11 Derivados peptidicos antiherpes, isostericos y procedimiento para su preparacion. MX9301343A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84991892A 1992-03-12 1992-03-12

Publications (1)

Publication Number Publication Date
MX9301343A true MX9301343A (es) 1994-01-31

Family

ID=25306833

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301343A MX9301343A (es) 1992-03-12 1993-03-11 Derivados peptidicos antiherpes, isostericos y procedimiento para su preparacion.

Country Status (24)

Country Link
EP (1) EP0560267B1 (cg-RX-API-DMAC7.html)
JP (1) JPH0625131A (cg-RX-API-DMAC7.html)
KR (1) KR950700322A (cg-RX-API-DMAC7.html)
AT (1) ATE169931T1 (cg-RX-API-DMAC7.html)
BR (1) BR9306074A (cg-RX-API-DMAC7.html)
CA (1) CA2131186C (cg-RX-API-DMAC7.html)
CZ (1) CZ220994A3 (cg-RX-API-DMAC7.html)
DE (1) DE69320390T2 (cg-RX-API-DMAC7.html)
EE (1) EE9400312A (cg-RX-API-DMAC7.html)
FI (1) FI944187A7 (cg-RX-API-DMAC7.html)
HU (2) HUT68675A (cg-RX-API-DMAC7.html)
IL (1) IL105001A0 (cg-RX-API-DMAC7.html)
LT (1) LT3270B (cg-RX-API-DMAC7.html)
LV (1) LV10461B (cg-RX-API-DMAC7.html)
MX (1) MX9301343A (cg-RX-API-DMAC7.html)
NO (1) NO943345L (cg-RX-API-DMAC7.html)
NZ (1) NZ251266A (cg-RX-API-DMAC7.html)
PH (1) PH30453A (cg-RX-API-DMAC7.html)
RU (1) RU94040865A (cg-RX-API-DMAC7.html)
SG (1) SG42995A1 (cg-RX-API-DMAC7.html)
SK (1) SK107794A3 (cg-RX-API-DMAC7.html)
TW (1) TW278080B (cg-RX-API-DMAC7.html)
WO (1) WO1993018056A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA931745B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2139169C (en) * 1994-12-28 2001-05-01 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes peptidomimetic compounds
US5846941A (en) * 1992-03-12 1998-12-08 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives II
CA2095408A1 (en) * 1993-05-03 1994-11-04 James Gus Chafouleas Method of combating acyclovir-resistant herpes simplex viral infections
CA2152541C (en) * 1995-06-23 1998-12-15 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Herpes ribonucleotide reductase inhibitors
US5948935A (en) * 1997-01-23 1999-09-07 Boehringer Ingelheim (Canada) Ltd. Process and intermediates for (s)-α-amino-1-carboxycyclopentaneacetic acid
DE69943314D1 (de) * 1998-02-12 2011-05-12 Kapil N Bhalla Sphingolipid-derivate und verfahren zu deren verwendung
AU2019339777B2 (en) 2018-09-12 2022-09-01 Novartis Ag Antiviral pyridopyrazinedione compounds
TWI867053B (zh) 2019-09-26 2024-12-21 瑞士商諾華公司 抗病毒吡唑并吡啶酮化合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US481432A (en) 1892-08-23 soler
US4795740A (en) 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
US4845195A (en) 1987-05-22 1989-07-04 Merck & Co., Inc. Inhibitor of ribonucleotide reductase
US4837304A (en) 1987-05-22 1989-06-06 Merck & Co., Inc. Inhibitor of ribonucleotide reductase
CA1340684C (en) 1989-07-07 1999-07-27 Pierre Louis Beaulieu Antiherpes pentapeptides
CA1340682C (en) * 1989-07-07 1999-07-27 Pierre Lavallee Antiviral peptides having a 2-oxoalkyl amino acid side chain
DE69019786T2 (de) * 1989-07-07 1995-11-16 Bio Mega Boehringer Ingelheim Antiherpes-Tetrapeptid-Derivate mit einer substituierten Seitenkette aus Asparaginsäure.
ATE118785T1 (de) 1989-07-07 1995-03-15 Bio Mega Boehringer Ingelheim Pentapeptidderivate, wirksam gegen herpes, die eine ersetzte asparaginsäureseitenkette enthalten.
US5110799A (en) 1989-07-28 1992-05-05 Merck & Co., Inc. Antiherpetic agents
CA2018801C (en) 1990-06-12 2000-08-22 Pierre Louis Beaulieu Antiherpes peptide derivatives having a 1,4-dioxo c n-terminus
CA2033447C (en) * 1990-12-31 1999-08-31 Robert Deziel Synergistic combination for treating herpes infections

Also Published As

Publication number Publication date
EP0560267A1 (en) 1993-09-15
KR950700322A (ko) 1995-01-16
DE69320390D1 (de) 1998-09-24
FI944187L (fi) 1994-09-12
SK107794A3 (en) 1995-03-08
LV10461B (en) 1996-02-20
BR9306074A (pt) 1997-11-18
HUT68675A (en) 1995-07-28
AU3880793A (en) 1993-10-05
TW278080B (cg-RX-API-DMAC7.html) 1996-06-11
EE9400312A (et) 1996-04-15
EP0560267B1 (en) 1998-08-19
JPH0625131A (ja) 1994-02-01
NZ251266A (en) 1996-08-27
ZA931745B (en) 1993-09-24
CA2131186C (en) 2000-12-12
AU671825B2 (en) 1996-09-12
DE69320390T2 (de) 1999-02-11
SG42995A1 (en) 1997-10-17
LV10461A (lv) 1995-02-20
CZ220994A3 (en) 1995-09-13
WO1993018056A1 (en) 1993-09-16
HU9402593D0 (en) 1994-11-28
ATE169931T1 (de) 1998-09-15
RU94040865A (ru) 1996-08-10
NO943345D0 (no) 1994-09-09
LT3270B (en) 1995-05-25
FI944187A0 (fi) 1994-09-12
CA2131186A1 (en) 1993-09-16
PH30453A (en) 1997-05-28
LTIP408A (en) 1994-09-25
IL105001A0 (en) 1993-07-08
FI944187A7 (fi) 1994-09-12
NO943345L (no) 1994-09-09
HU211926A9 (en) 1996-01-29

Similar Documents

Publication Publication Date Title
ES2095283T3 (es) Compuestos peptidicos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
BR9305162A (pt) Composto, formulação farmacêutica e processo para a preparação de um composto
ES2030777T3 (es) Un metodo para preparar un derivado de n-indanil-carboxamida, y fungicida agricola/horticola que contiene el derivado como ingrediente activo.
UY23635A1 (es) Procedimiento para la preparacion de conjugados del peg interferon
ES2032899T3 (es) Agente cosmetico para aplicacion externa y su uso.
ES2146784T3 (es) Composiciones de peracido espesadas.
AR005229A1 (es) Un derivado de 2,3-dioxo-1,2,3,4-tetrahidro-quinoxaliil y una composicion farmaceutica que lo comprende.
ES2171923T3 (es) Profarmacos de la talidomida, su procedimiento de preparacion y su utilizacion como principios activos en medicamentos.
MX9301343A (es) Derivados peptidicos antiherpes, isostericos y procedimiento para su preparacion.
ATE19251T1 (de) Hemmer der kollagenase der saeugetiere.
AR013462A1 (es) Nuevos peptidomimeticos para el tratamiento de trastornos oseos, metodos para su produccion y drogas que contienen estos compuestos
ES2090143T3 (es) Acidos gem-difosfonicos, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
PE13799A1 (es) Dihidropironas con actividad antiviral
ES2102870T3 (es) Benzopiranos y composiciones farmaceuticas que los contienen.
ES2057802T3 (es) Nuevos derivados de 3-amino-cromano, procedimiento de preparacion y composiciones farmaceuticas que los contienen.
AR014325A1 (es) Uso de glicinas n,n'-disustituidos o derivados de los mismos como desinfectantes antituberculosos y los desinfectantes antituberculososformulados con dichas glicinas n,n'-disustituidos
DE3584250D1 (de) Mittel zum stimulieren des haarwuchses.
ES2152269T3 (es) Inhibidores de ribonucleotido-reductasa de herpesvirus.
ES2089196T3 (es) Derivados de la vasotocina vasoactiva.
PE71799A1 (es) Derivados de benzoxazindiona, aplicacion de los mismos y medicamentos que los contienen
ES2164044T3 (es) Tetrahidroimidazo(1,4)benzodiazepin-2-(tio)onas antivirales.
NO954390L (no) Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner
PE20010307A1 (es) Derivados de rufomicina utiles como antibioticos
ES8702392A1 (es) Un procedimiento para preparar compuestos heterociclicos, en particular compuestos con un anillo de tiadiazinona
ES2069125T3 (es) Composiciones herbicidas.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees